Recare, a Berlin-based provider of technology solutions for hospitals and care providers, has closed a growth financing round up to 37 million euros, including a 7 million euro option.
The financing round has been led by DNV, the independent assurance and risk management provider, with additional participation from CIBC Innovation Banking and other investors. It makes DNV the largest shareholder in Recare.
Founded in 2017, Recare provides two-thirds of German hospitals and more than 26,000 care providers with a software-as-a-service platform that digitally simplifies discharge management and aftercare.
The new capital from the funding round will fast-track the introduction of a new AI agent to hospitals and care facilities and expand the company’s international business.
Maximilian Greschke, CEO of Recare, comments: “Hospitals are under enormous operational pressure, as healthcare professionals spend increasing time on administrative tasks—leaving less capacity for what matters most: caring for patients. Recare’s AI agent platform relieves a large part of this administrative burden by leveraging unstructured data to rapidly orchestrate workflows.
“The new investment into our business will accelerate the roll-out of our AI agent across Germany and abroad, helping healthcare providers to transform their workforce capacity.”
Charlotte Goggin, Director, CIBC Innovation Banking, comments: “We are pleased to support Recare as part of its latest funding round. For healthcare institutions, administrative tasks are time-consuming and take away from valuable hours that could be spent helping patients. Recare addresses this with its platform that maximises optionality for patients requiring aftercare solutions and streamlines the discharge and after-care processes.”